Novel epitopes identified by anti-PrP monoclonal antibodies produced following immunization of Prnp0/0 balb/cJ mice with purified scrapie prions

Hybridoma

Volumn 31, Issue 5, 2012, Pages 314-324

  Stanker, Larry H ^a   Scotcher, Miles C ^a   Lin, Alice ^a   McGarvey, Jeffery ^a   Prusiner, Stanley B ^b   Hnasko, Robert ^a  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DRM2 118; MONOCLONAL ANTIBODY DRM2 160; MONOCLONAL ANTIBODY DRM2 31; PRION PROTEIN; PROTEIN X; PROTEINASE K; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BINDING SITE; BRAIN; CONTROLLED STUDY; DISULFIDE BOND; EPITOPE MAPPING; FEMALE; IMMUNIZATION; LIPID RAFT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SCRAPIE AGENT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BINDING SITES, ANTIBODY; BLOTTING, WESTERN; BRAIN CHEMISTRY; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES; HUMANS; IMMUNIZATION; MEMBRANE MICRODOMAINS; MESOCRICETUS; MICE; MICE, TRANSGENIC; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; PRPSC PROTEINS;

MUS;

EID: 84868016019     PISSN: 15540014     EISSN: 15578348     Source Type: Journal    
DOI: 10.1089/hyb.2012.0022     Document Type: Article

References (36)

1. DeArmond SJ, Mobley WC, DeMott DL, Barry RA, Beck-stead JH, and Prusiner SB: Changes in the localization of brain prion proteins during scrapie infection. Neurology 1987;37:1271-1280.
2. Prusiner SB: Scrapie prions. Annu Rev Microbiol 1989;43: 345-374.
3. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, and Caughey WS: Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectros-copy. Biochemistry 1991;30:7672-7680.
4. Pan K-M, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, and Pru-siner SB: Conversion of α-helices into ß-sheets features in the formation of the scrapie prion proteins. Proc Nat Acad Sci USA 1993;90:10962-10966.
5. Prusiner SB, Scott M, Foster D, Pank M, Groth D, Mirenda C, Torchia M, Yang SL, Carlson GA, Hoppe PC, Westaway D, and DeArmond, SJ: Transgenic studies implicate interactions between homologous PrP isoforms in scrapie prion replica-tion. Cell 1990;63:673-686.
6. Safar J, Roller PP, Gajdusek DC, and Gibbs CJ Jr.: Thermal-stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity. Protein Sci 1993; 2:2206-2216.
7. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, and Wüthrich K: NMR structure of the mouse prion protein domain PrP(121-231). Nature 1996;382:180-182.
8. Supattapone S: Prion protein conversion in vitro. J Mol Med 2004;82:348-356.
9. Marijanovic Z, Caputo A, Campana V, and Zurzolo C: Identification of an intracellular site of prion conversion. PLoS Pathol 2009;5(5):e1000426. doi:10.1371/journal.ppat .1000426.
10. McKinley MP, Bolton DC, and Prusiner SB: A protease-resistant protein is a structural component of the scrapie prion. Cell 1983;1:57-62.
11. Sc directed antibodies. Neurochemistry 2008;105:2190-2204.
12. Sc)-specific epitope defined by a monoclonal antibody. Nature 1997;390:74-77.
13. Paramithiotis E, Pinard M, Lawton T, Laboissiere S, Leathers VL, Zou WQ, Estey LA, Lamontagne J, Lehto MT, Konde-jewski LH, Francoeur GP, Papadopoulos M, Haghighat A, Spatz SJ, Head M, Will R, Ironside J, O'Rourke K, Tonelli Q, Ledebur HC, Chakrabartty A, and Cashman NR: A prion protein epitope selective for the pathologically misfolded conformation. Nature Med 2003;9:893-899.
14. Sc fraction. Biochemistry 2006;51: 15710-15717.
15. Tsukamoto T, Diringer H, and Ludwig H: Absence of au-toantibodies against neurofilament proteins in the sera of scrapie infected mice. Tohoku J Exp Med 1985;4:483-484.
16. Clarke MC, and Haig DA: Attempts to demonstrate neu-tralising antibodies in the sera of scrapie-affected animals. Vet Rec 1966;19:647-649.
17. Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang SL, and DeArmond SJ: Ablation of the prion protein (PrP) gene in mice prevents scrapie and facil-itates production of anti-PrP antibodies. Proc Nat Acad Sci USA 1993;22:10608-10612.
18. Hnasko R, Serban AV, Carlson G, Prusiner SB, and Stanker LH: Generation of antisera to purified prions in lipid rafts. Prion 2010:4:94-102.
19. Williamson RA, Peretz D, Smorodinsky N, Bastidas R, Ser-ban H, Mehlhorn I, DeArmond SJ, Prusiner SB, and Burton DR: Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein. Proc Nat Acad Sci USA 1996;14:7279-7282.
20. Stanker LH, Serban AV, Cleveland E, Hnasko R, Safar J, and Prusiner SB: Conformation-dependent high-affinity MAbs to prion proteins. J Immunol 2010;185:729-737.
21. Mehlhorn I, Groth D, Stöckel J, Moffat B, Reilly D, Yansura D, Willett WS, Baldwin M, Fletterick R, Cohen FE, Vandlen R, Henner D, and Prusiner SB: High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 1996;35:5528-5537.
22. Legname G, Baskakov IV, Nguyen H-OB, Riesner D, Cohen FE, DeArmond SJ, and Prusiner SB: Synthetic mammalian prions. Science 2004;305:673-676.
23. Hnasko R, and Bruederle CE: Inoculation of scrapie with the self-assembling RADA-peptide disrupts prion accumulation and extends hamster survival. PLoS ONE 2009;4(2):e4440. doi:10.1371/journal.pone.0004440.
24. Stanker LH, Merrill P, Scotcher M, and Cheng L: Develop-ment and partial characterization of high-affinity monoclo-nal antibodies for Botulinum toxin type A. J Immunol Methods 2008;336:1-8.
25. Wang Z, Raifu M, Howard M, Smith L, Hansen D, Goldsby R, and Ratner D: Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of de-generate primers and an assessment of the effect of DNA polymerase 3' to 5' exonuclease activity. J Immunol Methods 2000;233:167-177.
26. Miller JH: Experiments in Molecular Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1972.
27. Scotcher MC, Johnson EA, and Stanker LH: Characterization of the epitope region of F1-2 and F1-5, two monoclonal an-tibodies to Botulinum neurotoxin type A using recombinant peptide fragments of the toxin heavy chain and phage dis-play. Hybridoma 2009;28:315-325.
28. Morrison S: Cloning, expression and modification of anti-body V regions. Curr Prot Immunol 2002; 2.12.11-12.12.17.
29. Wood DL, and Coleclough C: Different joining region J el-ements of the murine kappa immunoglobulin light chain locus are used at markedly different frequencies. Proc Natl Acad Sci USA 1984;81(15):4756-4760.
30. Recinos A, Silvey KJ, Ow DJ, Jensen RH, and Stanker LH: Sequences of cDNAs encoding immunoglobulin heavy- and light-chain variable regions from two anti-dioxin monoclo-nal antibodies. Gene 1994;149(2):385-386.
31. Recinos A, Silvey KJ, Ow DJ, Jensen RH, and Stanker LH: Sequences of cDNAs encoding immunoglobulin heavy- and light-chain variable regions from two anti-dioxin monoclo-nal antibodies Gene [1994;149:385-386];1995;158(2):311-312.
32. Livesay DR, and Subramaniam S: Conserved sequence and structure association motifs in antibody-protein and anti-body-hapten complexes. Protein Eng Des Sel 2004;17(5): 463-472.
33. James TL, Liu H, Ulyanov NB, Farr-Jones S, Zhang H, Donne DG, Kaneko K, Groth D, Melhorn I, Prusiner S, and Cohen F: Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie iso-form. Proc Nat Acad Sci USA 1997;94:10086-10091.
34. Pérez DR, Damberger FF, and Wüthrich K: Horse prion protein NMR structure and comparisons with related vari-ants of the mouse prion protein. J Mol Biol 2010;400:121-128.
35. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, Cohen FE, and Prusiner SB: Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Nat Acad Sci USA 1997;94:10069-10074.
36. Polymenidou M, Moos R, Scott M, Sigurdson C, Shi Y-Z, et al: The POM monoclonals: a comprehensive set of anti-bodies to non-overlapping prion protein epitopes. PLoS ONE 2008;3(12):e3872. doi:10.1371/journal.pone.0003872.